Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126092691 | 12609269 | 1 | I | 20010312 | 20160718 | 20160801 | 20160801 | EXP | GB-AUROBINDO-AUR-APL-2016-09607 | AUROBINDO | 28.00 | YR | F | Y | 0.00000 | 20160730 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126092691 | 12609269 | 1 | PS | Paroxetine Tablet | PAROXETINE | 1 | Unknown | UNK | U | U | 78406 | TABLET | |||||||
| 126092691 | 12609269 | 2 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ORAL SOLUTION | |||||||
| 126092691 | 12609269 | 3 | SS | SEROXAT | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 30 MG, UNK | U | U | 0 | 30 | MG | ||||||
| 126092691 | 12609269 | 4 | C | DIAZEPAM. | DIAZEPAM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126092691 | 12609269 | 1 | Product used for unknown indication |
| 126092691 | 12609269 | 2 | Product used for unknown indication |
| 126092691 | 12609269 | 3 | Product used for unknown indication |
| 126092691 | 12609269 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126092691 | 12609269 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126092691 | 12609269 | Agoraphobia | |
| 126092691 | 12609269 | Anxiety | |
| 126092691 | 12609269 | Depression | |
| 126092691 | 12609269 | Dizziness | |
| 126092691 | 12609269 | Drug withdrawal syndrome | |
| 126092691 | 12609269 | Fatigue | |
| 126092691 | 12609269 | Flat affect | |
| 126092691 | 12609269 | Hyperhidrosis | |
| 126092691 | 12609269 | Migraine with aura | |
| 126092691 | 12609269 | Movement disorder | |
| 126092691 | 12609269 | Nausea | |
| 126092691 | 12609269 | Neurosis | |
| 126092691 | 12609269 | Panic attack | |
| 126092691 | 12609269 | Paraesthesia | |
| 126092691 | 12609269 | Psychotic disorder | |
| 126092691 | 12609269 | Stress | |
| 126092691 | 12609269 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126092691 | 12609269 | 1 | 20020110 | 20160311 | 0 | |
| 126092691 | 12609269 | 2 | 20000126 | 20021021 | 0 | |
| 126092691 | 12609269 | 3 | 2000 | 0 | ||
| 126092691 | 12609269 | 4 | 20011121 | 0 |